Senegal vs Yemen: Population requiring preventive chemotherapy for schistosomiasis
Senegal
3.38 million
in 2024
Yemen
3.85 million
in 2024
Senegal rank
23rd
Yemen rank
21st
Population requiring preventive chemotherapy for schistosomiasis over time
- Senegal
- Yemen
How they compare
Yemen currently reports 3.85 million against 3.38 million in Senegal, a difference of 469,570.
That makes Yemen's figure about 1.1 times Senegal's.
The two have swapped places 4 times across 15 shared years of data; in 2010 it was Yemen ahead.
Senegal ranks 23rd and Yemen ranks 21st of 52 countries.
Yemen has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Senegal | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.81 million | 6.08 million | 2.27 million | Yemen |
| 2020s | 2.93 million | 3.75 million | 821,012 | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Senegal or Yemen?
- Yemen, at 3.85 million against 3.38 million in Senegal as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Senegal and Yemen?
- 469,570, with Yemen ahead.
- How many years of comparable data are there for Senegal and Yemen?
- 15 years are reported by both, from 2010 to 2024.
- How do Senegal and Yemen rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Senegal ranks 23rd and Yemen ranks 21st of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.